Literature DB >> 23302070

Response to the letter by Dr Chin and co-workers.

Sebastian Härtter, Michael Koenen-Bergmann, Ashish Sharma, Gerhard Nehmiz, Ute Lemke, Wolfgang Timmer, Paul A Reilly.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 23302070      PMCID： PMC3579271          DOI： 10.1111/j.1365-2125.2012.04407.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN： 0306-5251            Impact factor:   4.335


× No keyword cloud information.
  2 in total

1.  Rifampicin and dabigatran etexilate: a place for laboratory coagulation monitoring.

Authors:  Paul K L Chin; Murray L Barclay; Evan J Begg
Journal:  Br J Clin Pharmacol       Date:  2013-02       Impact factor: 4.335

2.  Decrease in the oral bioavailability of dabigatran etexilate after co-medication with rifampicin.

Authors:  Sebastian Härtter; Michael Koenen-Bergmann; Ashish Sharma; Gerhard Nehmiz; Ute Lemke; Wolfgang Timmer; Paul A Reilly
Journal:  Br J Clin Pharmacol       Date:  2012-09       Impact factor: 4.335
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.